# ARS Pharmaceuticals, Inc.: Form 8-K, filed Mar 23, 2023

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2023-03-23
- Accepted by EDGAR: Mar 23, 2023, 16:09 ET
- Period: 2023-03-23
- Accession: 0000950170-23-009485
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000095017023009485/sbtx-20230323.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000095017023009485/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000095017023009485/sbtx-20230323.htm

Filed Mar 23, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-009485. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
